申请人:Jadav Kanaksinh Jesingbhai
公开号:US20130041150A1
公开(公告)日:2013-02-14
The present invention provides a process for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof, having the R-configuration, of formula (IA), or S-configuration of formula (IB), selectively over the other enantiomer.
本发明提供了一种制备式(I)化合物或其药学上可接受的盐的过程,该化合物具有R构型的式(IA)或S构型的式(IB),并且能够选择性地制备其中一种对映异构体,而不是另一种对映异构体。